Why is Maitreya Medica. falling/rising?

As of 23-Sep, Maitreya Medicare Ltd's stock price is currently at 240.00, reflecting a decline of 6.95, or 2.81%. The stock has underperformed its sector by 2.34% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 2.81%, and its year-to-date performance shows a significant drop of 28.60%. Additionally, the company's profits have fallen by 40% over the past year, contributing to a total return of -37.42% in the last year. The recent quarterly performance indicates a substantial decline in profit after tax and operating profit, which are at their lowest levels.
In the broader market context, Maitreya Medicare Ltd's short-term performance has been notably worse than the benchmark, with the Sensex only declining by 0.28% over the same week. This stark contrast highlights the stock's struggles, as it has consistently underperformed against the BSE500 over various time frames. Despite having a low Debt to EBITDA ratio indicating a strong ability to service debt and an attractive valuation with a Price to Book Value of 5.1, the company's long-term growth prospects appear poor, with an annual operating profit decline of 22.52% over the last five years. This combination of factors has led to a negative sentiment surrounding the stock, contributing to its current downward trajectory.